Sequential Responses of Adenocarcinoma of the Lung to Erlotinib after Gefitinib in Never Smoker Korean Woman

A patient with adenocarcinoma of the lung was treated sequentially using two kinds of EGFR tyrosine kinase inhibitors, gefitinib and erlotinib. The patient was a 73-year-old female who received gefitinib as a second line treatment, which resulted in a partial response with response duration of 6 mon...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Kim, Hoon-Kyo, Ahn, Myeong Im, Yoo, Jinyoung, Kim, Chi Hong, Yang, Hong-Jun, Shim, Byoung Yong
Materialtyp: Artigo
Språk:Inglês
Publicerad: Korean Cancer Association 2007
Ämnen:
Case Report
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC2739363/
https://ncbi.nlm.nih.gov/pubmed/19746235
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4143/crt.2007.39.1.37
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk